What is the price of IGC stock?
One share of IGC stock can currently be purchased for approximately $1.03. How much money does India Globalization Capital make? India Globalization Capital has a market capitalization of $52.59 million and generates $900 thousand in revenue each year.
What did this CEO just do with personal shares of IGC?
Too much love from investors What Did This CEO Just Do with Personal Shares of India Globalization Capital (IGC)? India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications, such as Alzheimer's disease, Parkinson's disease, and pain.
Is India Globalization Capital Inc (IGC) a good buy?
India Globalization Capital Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
What is India globalization capital's stock symbol?
What is India Globalization Capital's stock symbol? India Globalization Capital trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "IGC." Who are India Globalization Capital's major shareholders?
How has India Globalization Capital's stock price performed in 2022?
India Globalization Capital's stock was trading at $0.9116 at the beginning of the year. Since then, IGC shares have decreased by 53.5% and is now...
When is India Globalization Capital's next earnings date?
India Globalization Capital is scheduled to release its next quarterly earnings announcement on Monday, June 13th 2022. View our earnings forecast...
How were India Globalization Capital's earnings last quarter?
India Globalization Capital, Inc. (NYSEAMERICAN:IGC) issued its earnings results on Monday, February, 10th. The construction company reported ($0.0...
Who are India Globalization Capital's key executives?
India Globalization Capital's management team includes the following people: Mr. Ram Mukunda , Exec. Chairman, Pres & CEO (Age 63, Pay $801k) Ms...
Who are some of India Globalization Capital's key competitors?
Some companies that are related to India Globalization Capital include Orbital Energy Group (OEG) , TESSCO Technologies (TESS) , Taitron Compone...
What other stocks do shareholders of India Globalization Capital own?
Based on aggregate information from My MarketBeat watchlists, some companies that other India Globalization Capital investors own include GW Pharm...
What is India Globalization Capital's stock symbol?
India Globalization Capital trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "IGC."
Who are India Globalization Capital's major shareholders?
India Globalization Capital's stock is owned by many different institutional and retail investors. Top institutional investors include Mirae Asset...
Which major investors are selling India Globalization Capital stock?
IGC stock was sold by a variety of institutional investors in the last quarter, including Davy Global Fund Management Ltd, Mirae Asset Global Inves...
What is India Globalization Capital?
Does liquidity reduce risk?
India Globalization Capital, Inc. researches on phytocannabinoid-based therapies and develops intellectual property for the treatment of life altering or life threatening conditions. It also leases equipment, trade commodities, and electronic components in India and China. In addition, the company operates an e-commerce platform for the trading of commodities and electronic components; and supplies components for original equipment manufacturers ... Read more
Is India Globalization Capital Inc a sell or buy signal?
Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The India Globalization Capital Inc stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal.
When will IGC report financial results?
The India Globalization Capital Inc stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $1.59. On a fall, the stock will find some support from the long-term average at approximately $1.52. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. The volume rose on the last day while price remained unchanged. This may be an early warning and the stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 01, 2021, and so far it has fallen -11.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 months Moving Average Convergence Divergence (MACD).
Is IGC a phase 1 company?
IGC Reports Financial Results for December 31, 2020 Quarter. IGC announced its financial results for the quarter ended December 31, 2020, which is the third quarter of its 2021 fiscal year. Business Wire • 7 months ago.
Does Brenden Rearick have any positions in the securities mentioned in this article?
India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) announced that it is enrolling participants suffering from mild to severe dementia due to Alzheimer’s disease for its Phase 1 clinical trial.
Is IGC AD1 a patent?
On the date of publication, Brenden Rearick did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Is IGC stock boosted?
The U.S. Patent and Trademark Office is officially issuing the patent for IGC’s Alzheimer’s treatment today.
Why did IGC spike?
It appears IGC stock is being boosted by a patent issued to the company for its cannabis-derived Alzheimer’s treatment. Alzheimer’s disease is a hot topic among biotech and pharmaceutical companies. Biogen (NASDAQ: BIIB) brought the illness to the forefront of the industry’s attention with the approval of its drug Aduhelm.
Why Is This A Big Deal?
IGC spiked because any treatment for Alzheimer’s is a really big deal. There are also a lot of favorable technical factors that can keep the momentum going in IGC stock.
